XML 66 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net income $ 1,127 $ 11,521
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,973 2,103
Net amortization of premiums on securities 562 528
Provision for credit losses 13,915 1,193
Share-based compensation 332 182
Deferred income tax expense (benefit) (276) 951
Proceeds from sale of loans held for sale 9,934 5,992
Originations of loans held for sale (9,228) (5,011)
Income on company owned life insurance (465) (410)
Net gain on sale of loans held for sale (304) (182)
Net (gain) loss on investment securities (221) 53
Net gain on other assets (64) (49)
(Increase) decrease in other assets (31,708) 1,471
Increase (decrease) in other liabilities 18,745 (2,984)
Net cash provided by operating activities 4,322 15,358
Cash flows from investing activities:    
Purchases of available for sale securities (44,812) (7,681)
Purchases of held to maturity securities (1,364) (4,466)
Proceeds from principal payments, maturities and calls on available for sale securities 13,847 25,390
Proceeds from principal payments, maturities and calls on held to maturity securities 13,827 12,842
Proceeds from sales of securities available for sale 20,257 4,948
Net loan originations (27,029) (24,361)
Purchases of company owned life insurance, net of proceeds received (7) (24)
Proceeds from sales of other assets 427 250
Purchases of premises and equipment (1,196) (575)
Net cash (used in) provided by investing activities (26,050) 6,323
Cash flows from financing activities:    
Net increase in deposits 231,510 141,930
Net decrease in short-term borrowings (166,000) (182,200)
Purchases of common stock for treasury (196) (193)
Cash dividends paid to common and preferred shareholders (4,365) (4,187)
Net cash provided (used in) by financing activities 60,949 (44,650)
Net increase (decrease) in cash and cash equivalents 39,221 (22,969)
Cash and cash equivalents, beginning of period 112,947 102,755
Cash and cash equivalents, end of period $ 152,168 $ 79,786